Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Патологическое прикрепление плаценты (предлежание и врастание плаценты)

Список литературы

  1. Erm Jauniaux,Z Alfirevic,A G Bhide,M A Belfort,G J Burton,S L Collins,S Dornan,D Jurkovic,G Kayem,J Kingdom,R Silver L.S. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a // BJOG An Int. J. Obstet. Gynaecol. 2018.
  2. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management // BJOG An Int. J. Obstet. Gynaecol. 2019. Vol. 126, № 1. P. e1–e48.
  3. Guideline No. 402 Diagnosis ana Management of Placenta Previa. J Obstet GynaecolCan. 2020.
  4. De Mucio B. et al. A systematic review and meta‐analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta // Int. J. Gynecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  5. Chen Y. et al. Persistent hypoxia induced autophagy leading to invasiveness of trophoblasts in placenta accreta. // J. Matern. Fetal. Neonatal Med. 2021. Vol. 34, № 8. P. 1297–1303.
  6. Timor-Tritsch I.E. et al. Cesarean scar pregnancy and early placenta accreta share common histology. // Ultrasound Obstet. Gynecol. 2014. Vol. 43, № 4. P. 383–395.
  7. Society of Gynecologic Oncology et al. Placenta Accreta Spectrum. // Am. J. Obstet. Gynecol. 2018. Vol. 219, № 6. P. B2–B16.
  8. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2017. Vol. 217, № 1. P. 27–36.
  9. Morlando M. et al. Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2020. Vol. 99, № 10. P. 1278–1289.
  10. Jauniaux E. et al. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. // BMJ Open. 2019. Vol. 9, № 11. P. e031193.
  11. Martimucci K. et al. Interpregnancy interval and abnormally invasive placentation. // Acta Obstet. Gynecol. Scand. 2019. Vol. 98, № 2. P. 183–187.
  12. Castaneda S., Karrison T., Cibils L.A. Peripartum hysterectomy. // J. Perinat. Med. 2000. Vol. 28, № 6. P. 472–481.
  13. Iacovelli A. et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 3. P. 471–481.
  14. Fitzpatrick K.E. et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. // PLoS One. 2012. Vol. 7, № 12. P. e52893.
  15. Calì G. et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 169–175.
  16. Kohn J.R. et al. Pregnancy after endometrial ablation: a systematic review. // BJOG. 2018. Vol. 125, № 1. P. 43–53.
  17. Marshall N.E., Fu R., Guise J.-M. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. // Am. J. Obstet. Gynecol. 2011. Vol. 205, № 3. P. 262.e1-8.
  18. Weis M.A. et al. Natural history of placenta previa in twins. // Obstet. Gynecol. 2012. Vol. 120, № 4. P. 753–758.
  19. Read J.A., Cotton D.B., Miller F.C. Placenta accreta: changing clinical aspects and outcome. // Obstet. Gynecol. 1980. Vol. 56, № 1. P. 31–34.
  20. Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. // Am. J. Obstet. Gynecol. 2005. Vol. 192, № 5. P. 1458–1461.
  21. Amin M.B. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. // CA. Cancer J. Clin. 2017. Vol. 67, № 2. P. 93–99.
  22. Reddy U.M. et al. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecolog // J. Ultrasound Med. 2014. Vol. 33, № 5. P. 745–757.
  23. Jauniaux E. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. // Int. J. Gynaecol. Obstet. 2019. Vol. 146, № 1. P. 20–24.
  24. Palacios-Jaraquemada J.M. et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 19. P. 3377–3384.
  25. Expert Panel on Women’s Imaging et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder. // J. Am. Coll. Radiol. 2020. Vol. 17, № 5S. P. S207–S214.
  26. Савельева Г.М., Курцер М.А., Бреслав И.Ю., Панина О.Б., Андреев А.И., Барыкина О.П. Л.О.А. Врастание предлежащей плаценты (placenta accreta) у пациенток с рубцом на матке после кесарева сечения. Клинико-морфологическое сопоставление // Акушерство и Гинекология. 2015.
  27. Jain V., Bos H., Bujold E. Guideline No. 402: Diagnosis and Management of Placenta Previa // J. Obstet. Gynaecol. Canada. 2020. Vol. 42, № 7. P. 906-917.e1.
  28. Zhou L.M. et al. Relation of hemoglobin measured at different times in pregnancy to preterm birth and low birth weight in Shanghai, China. // Am. J. Epidemiol. 1998. Vol. 148, № 10. P. 998–1006.
  29. Steer P., Alam M.A., Wadsworth J. W.A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. // BMJ. 1995. P. 310(6978):489–91.
  30. Abide Yayla C. et al. Predictive value of complete blood count parameters for placental invasion anomalies // J. Matern. Neonatal Med. 2017. Vol. 30, № 19. P. 2324–2328.
  31. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force. // Transfus. Med. 1996. Vol. 6, № 1. P. 71–74.
  32. UK Blood Transfusion Services. Guidelines for the Blood Transfusion Service. 8th ed. London: TSO; 2013.
  33. Walker G.J. Antibiotics for syphilis diagnosed during pregnancy. // Cochrane database Syst. Rev. 2001. № 3. P. CD001143.
  34. Watson-Jones D. et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. // J. Infect. Dis. 2002. Vol. 186, № 7. P. 948–957.
  35. Volmink J. et al. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. // Cochrane database Syst. Rev. 2007. № 1. P. CD003510.
  36. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders // J. Obstet. Gynaecol. Canada. 2019. Vol. 41, № 7. P. 1035–1049.
  37. Wong V.C. et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. // Lancet (London, England). 1984. Vol. 1, № 8383. P. 921–926.
  38. Xu Z.Y. et al. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. // Pediatrics. 1985. Vol. 76, № 5. P. 713–718.
  39. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. // J. Obstet. Gynaecol. Can. 2019. Vol. 41, № 7. P. 1035–1049.
  40. Smaill F.M. Intrapartum antibiotics for Group B streptococcal colonisation // The Cochrane Database of Systematic Reviews / ed. Smaill F.M. Chichester, UK: John Wiley & Sons, Ltd, 1996.
  41. Benitz W.E., Gould J.B., Druzin M.L. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. // Pediatrics. 1999. Vol. 103, № 6. P. e78.
  42. Prevention of Early-onset Neonatal Group B Streptococcal Disease // BJOG An Int. J. Obstet. Gynaecol. 2017. Vol. 124, № 12. P. e280–e305.
  43. D’Antonio F. et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 176–183.
  44. Panaiotova J. et al. Screening for morbidly adherent placenta in early pregnancy. // Ultrasound Obstet. Gynecol. 2019. Vol. 53, № 1. P. 101–106.
  45. Melcer Y. et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. // Am. J. Obstet. Gynecol. 2018. Vol. 218, № 4. P. 443.e1-443.e8.
  46. Stafford I.A. et al. Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa. // Obstet. Gynecol. 2010. Vol. 116, № 3. P. 595–600.
  47. Zaitoun M.M. et al. Does cervical length and the lower placental edge thickness measurement correlates with clinical outcome in cases of complete placenta previa? // Arch. Gynecol. Obstet. 2011. Vol. 284, № 4. P. 867–873.
  48. Buca D. et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 52, № 3. P. 304–309.
  49. Jauniaux E. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. // Int. J. Gynaecol. Obstet. 2018. Vol. 140, № 3. P. 274–280.
  50. D’Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2013. Vol. 42, № 5. P. 509–517.
  51. Collins S.L. et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 271–275.
  52. Alfirevic Z. et al. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 276–278.
  53. D’Antonio F. et al. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2014. Vol. 44, № 1. P. 8–16.
  54. Neilson J.P. Interventions for suspected placenta praevia. // Cochrane database Syst. Rev. 2003. № 2. P. CD001998.
  55. Familiari A. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2018. Vol. 97, № 5. P. 507–520.
  56. Poder L. et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder // J. Am. Coll. Radiol. 2020. Vol. 17, № 5. P. S207–S214.
  57. Obstetric Care Consensus No. 7 Summary: Placenta Accreta Spectrum // Obstet. Gynecol. 2018. Vol. 132, № 6. P. 1519–1521.
  58. Obstetric care consensus // Am. Coll. Obstet. Gynecol. 2012. Vol. 529. P. 259–275.
  59. Jha P. et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. // Eur. Radiol. 2020. Vol. 30, № 5. P. 2604–2615.
  60. Hecht J.L. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. // Mod. Pathol. 2020. Vol. 33, № 12. P. 2382–2396.
  61. Wing D.A., Paul R.H., Millar L.K. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. // Am. J. Obstet. Gynecol. 1996. Vol. 175, № 4 Pt 1. P. 806–811.
  62. Pivano A. et al. A score to predict the risk of emergency caesarean delivery in women with antepartum bleeding and placenta praevia. // Eur. J. Obstet. Gynecol. Reprod. Biol. 2015. Vol. 195. P. 173–176.
  63. Ruiter L. et al. Predictors for Emergency Cesarean Delivery in Women with Placenta Previa. // Am. J. Perinatol. 2016. Vol. 33, № 14. P. 1407–1414.
  64. Балашова Е.Н., Ионов О.В., Киртбая А.Р., Никонец А.Д., Михеева А.А., Васильченко О.Н., Зубков В.В., Шмаков Р.Г. Д.Д.Н. Особенности дыхательных и сердечно-сосудистых нарушений у недоношенных детей, рожденных у матерей с врастанием плаценты // Акушерство и гинекология. 2021.
  65. Silver R.M. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. // Obstet. Gynecol. 2015. Vol. 126, № 3. P. 654–668.
  66. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. // BJOG. 2019. Vol. 126, № 1. P. e1–e48.
  67. Seif K.E. et al. Neonatal Outcomes in Pregnancies Complicated by Placenta Accreta Spectrum // Am. J. Obstet. Gynecol. 2022. Vol. 226, № 1. P. S749–S750.
  68. Ahn K.H. et al. Anterior placenta previa in the mid-trimester of pregnancy as a risk factor for neonatal respiratory distress syndrome // PLoS One / ed. Mastrolia S.A. 2018. Vol. 13, № 11. P. e0207061.
  69. Tsuda H. et al. Effect of placenta previa on neonatal respiratory disorders and amniotic lamellar body counts at 36–38weeks of gestation // Early Hum. Dev. 2014. Vol. 90, № 1. P. 51–54.
  70. Stafford I.A. et al. Cervical Pessary versus Expectant Management for the Prevention of Delivery Prior to 36 Weeks in Women with Placenta Previa: A Randomized Controlled Trial. // AJP Rep. 2019. Vol. 9, № 2. P. e160–e166.
  71. Barinov S. V et al. The role of cervical pessary and progesterone therapy in the phenomenon of placenta previa migration. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 6. P. 913–919.
  72. Abbas F. et al. Placenta percreta with bladder invasion as a cause of life threatening hemorrhage. // J. Urol. 2000. Vol. 164, № 4. P. 1270–1274.
  73. Washecka R., Behling A. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. // Hawaii Med. J. 2002. Vol. 61, № 4. P. 66–69.
  74. Виницкий А.А., Шмаков Р.Г. Б.В.Г. Современные методы инструментальной диагностики врастания плаценты // Акушерство и гинекология. 2017.
  75. Collins S.L. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. // Am. J. Obstet. Gynecol. 2019. Vol. 220, № 6. P. 511–526.
  76. Eller A.G. et al. Optimal management strategies for placenta accreta. // BJOG. 2009. Vol. 116, № 5. P. 648–654.
  77. РОАГ. Клинические рекомендации «Послеродовое кровотечение». 2021.
  78. Клинические рекомендации «Роды одноплодные, родоразрешение путем кесарева сечения». 2021.
  79. Taylor N.J., Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. // Int. J. Obstet. Anesth. 2017. Vol. 30. P. 10–15.
  80. Курцер М.А. et al. Врастание плаценты // Акушерство и гинекология. 2002. Vol. 99, № 1. P. 169–170.
  81. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. // Can. J. Anaesth. 2016. Vol. 63, № 11. P. 1233–1244.
  82. Khokhar R. et al. Placenta accreta and anesthesia: A multidisciplinary approach // Saudi J. Anaesth. 2016. Vol. 10, № 3. P. 332.
  83. Kocaoglu N. et al. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: a retrospective study. // Ginekol. Pol. 2012. Vol. 83, № 2. P. 99–103.
  84. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases // Can. J. Anesth. Can. d’anesthésie. 2016. Vol. 63, № 11. P. 1233–1244.
  85. Markley J.C. et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. // Anesth. Analg. 2018. Vol. 127, № 4. P. 930–938.
  86. Schmidt G.A. et al. Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline // Chest. 2017. Vol. 151, № 1. P. 160–165.
  87. Aoki M. et al. Primary postpartum hemorrhage: outcome of uterine artery embolization // Br. J. Radiol. 2018. P. 20180132.
  88. Fyodorova T.A. et al. Massive Hemorrhages in Pregnant Women with Placenta Previa and Accreta: a Transfusiologist’s View // Russ. Sklifosovsky J. “Emergency Med. Care.” 2018. Vol. 7, № 3. P. 253–259.
  89. Muñoz M. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. // Blood Transfus. 2019. Vol. 17, № 2. P. 112–136.
  90. Spruit M.A. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. // Am. J. Respir. Crit. Care Med. 2013. Vol. 188, № 8. P. e13-64.
  91. Muñoz M. et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. // Transfus. Med. 2018. Vol. 28, № 1. P. 22–39.
  92. Becuzzi N., Zimmermann R., Krafft A. Long-term efficacy of postpartum intravenous iron therapy. // Biomed Res. Int. 2014. Vol. 2014. P. 815437.
  93. Muñoz M. et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. // Anaesthesia. 2017. Vol. 72, № 2. P. 233–247.
  94. Smulian J.C. et al. Invasive placental disease: the impact of a multi-disciplinary team approach to management. // J. Matern. Fetal. Neonatal Med. 2017. Vol. 30, № 12. P. 1423–1427.
  95. Al-Khan A. et al. Maternal and Fetal Outcomes in Placenta Accreta After Institution of Team-Managed Care // Reprod. Sci. 2014. Vol. 21, № 6. P. 761–771.
  96. Eller A.G. et al. Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared With Standard Obstetric Care // Obstet. Gynecol. 2011. Vol. 117, № 2. P. 331–337.
  97. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-9.
  98. Silver R.M. et al. Center of excellence for placenta accreta. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 5. P. 561–568.
  99. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-218.e9.
  100. Publications Committee S. for M.-F.M., Belfort M.A. Placenta accreta. // Am. J. Obstet. Gynecol. 2010. Vol. 203, № 5. P. 430–439.
  101. Rac M.W.F. et al. Placenta accreta and vaginal bleeding according to gestational age at delivery. // Obstet. Gynecol. 2015. Vol. 125, № 4. P. 808–813.
  102. Bowman Z.S. et al. Risk factors for unscheduled delivery in patients with placenta accreta. // Am. J. Obstet. Gynecol. 2014. Vol. 210, № 3. P. 241.e1-6.
  103. Fishman S.G., Chasen S.T. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. // J. Perinat. Med. 2011. Vol. 39, № 6. P. 693–696.
  104. Pri-Paz S. et al. Comparison between emergent and elective delivery in women with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2013. Vol. 26, № 10. P. 1007–1011.
  105. Warshak C.R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. // Obstet. Gynecol. 2010. Vol. 115, № 1. P. 65–69.
  106. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. // Obstet. Gynecol. 2010. Vol. 116, № 4. P. 835–842.
  107. Seoud M.A. et al. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. // J. Neonatal. Perinatal. Med. 2017. Vol. 10, № 1. P. 9–15.
  108. Angstmann T. et al. Surgical management of placenta accreta: a cohort series and suggested approach. // Am. J. Obstet. Gynecol. 2010. Vol. 202, № 1. P. 38.e1-9.
  109. Wade R. et al. Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis // Health Technol. Assess. (Rockv). 2015. Vol. 19, № 98. P. 1–220.
  110. Palacios-Jaraquemada J.M. et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. // J. Matern. Fetal. Neonatal Med. 2020. P. 1–8.
  111. Kotsuji F. et al. Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. // BJOG. 2013. Vol. 120, № 9. P. 1144–1149.
  112. Шмаков Р.Г., Пирогова М.М., Васильченко О.Н., Чупрынин В.Д. Е.Л.С. Хирургическая тактика при врастании плаценты с различной глубиной инвазии // Акушерство и гинекология. 2020.
  113. Shmakov R.G. et al. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery // J. Matern. Neonatal Med. 2019. Vol. 32, № 12. P. 2042–2048.
  114. Teixidor Viñas M. et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. // Ultrasound Obstet. Gynecol. 2015. Vol. 46, № 3. P. 350–355.
  115. Alanis M. et al. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. // Fertil. Steril. 2006. Vol. 86, № 5. P. 1514.e3-7.
  116. Kilicci C. et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. // J. Matern. Fetal. Neonatal Med. 2018. Vol. 31, № 22. P. 2935–2940.
  117. Clausen C., Lönn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. // Acta Obstet. Gynecol. Scand. 2014. Vol. 93, № 2. P. 138–143.
  118. Savelieva G.M. et al. [Development and practical implementation of organ preservation surgery in case of placenta accreta in patients with a scar on the uterus]. // Probl. sotsial’noi Gig. Zdr. i Istor. meditsiny. 2019. Vol. 27, № Special Issue. P. 693–698.
  119. Курцер М.А. Г.А.М. Временная баллонная окклюзия при врастании плаценты // Эндоваскулярная хирургия. 2020. Vol. т.7 № 2 ст.
  120. Shahin A.Y. et al. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. // Int. J. Gynaecol. Obstet. 2010. Vol. 108, № 3. P. 187–190.
  121. Hwu Y.-M. et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. // BJOG. 2005. Vol. 112, № 10. P. 1420–1423.
  122. Баринов С.В., Тирская Ю.И. М.И.В.. Способ остановки послеродового кровотечения путем наложения гемостатического наружно-маточного сборочного надплацентарного шва // Российский вестник акушера-гинеколога. 2017.
  123. Mei J. et al. Systematic review of uterus-preserving treatment modalities for abnormally invasive placenta. // J. Obstet. Gynaecol. 2015. Vol. 35, № 8. P. 777–782.
  124. Pan Y. et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. // Int. J. Gynaecol. Obstet. 2017. Vol. 137, № 1. P. 45–50.
  125. Hussein A.M. et al. The role of prophylactic internal iliac artery ligation in abnormally invasive placenta undergoing caesarean hysterectomy: a randomized control trial. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, № 20. P. 3386–3392.
  126. Salim R. et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. // Obstet. Gynecol. 2015. Vol. 126, № 5. P. 1022–1028.
  127. Camuzcuoglu A. et al. Surgical management of 58 patients with placenta praevia percreta. // Wien. Klin. Wochenschr. 2016. Vol. 128, № 9–10. P. 360–366.
  128. Kayem G., Keita H. [Management of placenta previa and accreta]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2014. Vol. 43, № 10. P. 1142–1160.
  129. De Mucio B. et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. // Int. J. Gynaecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  130. Pather S. et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. // Aust. N. Z. J. Obstet. Gynaecol. 2014. Vol. 54, № 1. P. 84–87.
  131. Manzano Nunez R. et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. // World J. Emerg. Surg. 2017. Vol. 12. P. 30.
  132. Chen L. et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. // BMC Pregnancy Childbirth. 2019. Vol. 19, № 1. P. 30.
  133. Chu Q. et al. Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial. // Trials. 2017. Vol. 18, № 1. P. 240.
  134. Shahin Y., Pang C.L. Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis. // Eur. Radiol. 2018. Vol. 28, № 7. P. 2713–2726.
  135. Wei Y. et al. Evaluation of a modified “Triple-P” procedure in women with morbidly adherent placenta after previous caesarean section // Arch. Gynecol. Obstet. 2017. Vol. 296, № 4. P. 737–743.
  136. Dai Y.M. et al. [Intrauterine balloon tamponade combined with temporary abdominal aortic balloon occlusion in the management of women with placenta accreta spectrum:a randomized controlled trial]. // Zhonghua Fu Chan Ke Za Zhi. 2020. Vol. 55, № 7. P. 450–456.
  137. Suarez S. et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2020. Vol. 222, № 4. P. 293.e1-293.e52.
  138. Wei J. et al. Intrauterine double-balloon tamponade vs gauze packing in the management of placenta previa: A multicentre randomized controlled trial. // Medicine (Baltimore). 2020. Vol. 99, № 7. P. e19221.
  139. Tuzović L., Djelmis J., Ilijić M. Obstetric risk factors associated with placenta previa development: case-control study. // Croat. Med. J. 2003. Vol. 44, № 6. P. 728–733.
  140. Barinov S. et al. A new approach to fertility-preserving surgery in patients with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, № 9. P. 1449–1453.
  141. Виницкий А.А., Шмаков Р.Г. Ч.В.Д. Сравнительная оценка эффективности методов хирургического гемостаза при органосохраняющем родоразрешении у пациенток с врастанием плаценты // Акушерство и гинекология. 2017.
  142. Kee W.D.N., Khaw K.S., Ng F.F. Prevention of Hypotension during Spinal Anesthesia for Cesarean Delivery // Anesthesiology. 2005. Vol. 103, № 4. P. 744–750.
  143. Tzeng J.I. et al. Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline // Br. J. Anaesth. 2000. Vol. 85, № 6. P. 865–868.
  144. Курцер М.А., Бреслав И.Ю., Григорьян А.М. Л.О.А. Опыт использования временной баллонной окклюзии общих подвздошных артерий при органосохраняющих операциях у пациенток с врастанием плаценты // Акушерство и Гинекология. 2013.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*